MSDS Material Safety Data Sheet


File Name: 137330-13-3.asp

                                                                                 Page 1 of 8

Revision 3.8, 10 August 2005

"Hazardous according to criteria of Worksafe Australia"
Irritant; R43 May cause sensitisation by skin contact.

Company Name and Address:
Elanco Animal Health
A Division of Eli Lilly Australia Pty Ltd
A.B.N. 39 000 233 992
112 Wharf Road, West Ryde, N.S.W. 2114, Australia

Contact Numbers:
Tel: (02) 9878 7777
Fax: (02) 9878 7720

Emergency Telephone Numbers:
Elanco Animal Health:
1800 226 324 (Toll free)
Poisons Information Centre:
13 1126 (Australia-wide)

Section 1 - Identification

Product Name: Elanco AH0230 Micotil 300 Injection
Other Names: Tilmicosin
Manufacturer鈥檚 Product Code: AH0230
UN Number: None allocated
Dangerous Goods Class/Subsidiary Risk: None allocated
Hazchem Code: None allocated
Poisons Schedule Number: S4
Pack Size and Container Type: 100 mL multidose amber bottles for subcutaneous injection in
cattle only

Major Recommended Uses: For use in lot-fed cattle for the treatment of Bovine Respiratory
Disease (BRD) associated with Pasteurella haemolytica, Pasteurella multocida, and other
organisms susceptible to tilmicosin.

Major Recommended Method(s) of Application: For subcutaneous injection only in cattle.
Page 2 of 8

Section 2 - Composition / Information on Ingredients

Ingredient CAS Concentration %
Tilmicosin Phosphate 137330-13-3 30
Inert Ingredients NA 70

Contains no hazardous components (one percent or greater) or carcinogens (one-tenth percent
or greater) not listed above.

Exposure Guidelines: Tilmicosin - LEG <100 micrograms/m3 TWA for 12 hours.

Section 3 - Hazards Identification

Appearance: Clear yellow to amber-coloured solution
Physical State: Liquid
Odour: Faint characteristic sweet odour

Emergency Overview:
Primary Physical and Health Hazards: Severe Allergen. Heart Effects.

Caution Statement: Micotil 300 Injection contains tilmicosin phosphate and is classified as a
severe allergen because repeated unprotected exposures are likely to cause allergic reactions.
Effects of exposure may include changes in heart rate/rhythm and heart tissue changes.

Routes of Entry: Inhalation and skin contact.

Potential Signs and Symptoms of Occupational Exposure: Micotil 300 Injection - No allergic
reactions in a manufacturing setting have been reported.
Tilmicosin phosphate powder - Allergic reactions in a manufacturing setting have been
reported. Allergy symptoms may include skin rash, watery eyes, shortness of breath, nasal
congestion, choking, coughing, and wheezing. Compounds of similar structure have been
reported to cause transient alterations in heart rate.


Medical Conditions Aggravated by Exposure: Sensitivity to tilmicosin and/or tylosin.

Carcinogenicity: No carcinogenicity data found. Not listed by IARC, NTP, ACGIH, or

Section 4 - First Aid Measures
Human Warnings
Injection of MICOTIL Injection of Micotil 300 in humans has been associated with fatalities.
Keep out of reach of children. Do not use in automatically powered syringes. Exercise
extreme caution to avoid accidental self-injection. In case of human injection, consult a
doctor immediately and apply ice or cold pack to injection site while avoiding direct contact
with the skin. Contact Poisons Information Centre on 13 1126 . Avoid contact with eyes.
Do not massage injection site.
Page 3 of 8

Eyes: Hold eyes open and flush with a steady, gentle stream of water for 15 minutes. See an
ophthalmologist (eye doctor) or other physician immediately.

Skin: Remove contaminated clothing and clean before reuse. Wash all exposed areas of skin
with plenty of soap and water.

Inhalation: Move individual to fresh air. Get medical attention if breathing difficulty occurs.
If not breathing, provide artificial respiration assistance (mouth-to-mouth) and call a
physician immediately.

Ingestion: Call a physician or Poisons Information Centre immediately. Phone 13 1126
(Australia-wide). If available, administer activated charcoal (6-8 heaping teaspoons) with
two to three glasses of water. Do not give anything by mouth to an unconscious person.
Immediately transport to a medical care facility and see a physician.

The cardiovascular system is the target of toxicity and should be monitored closely.
Cardiovascular toxicity may be due to calcium channel blockade. In dogs, administration of
intravenous calcium offset Micotil-induced tachycardia and negative inotropy (decreased
contractility). Dobutamine partially offset the negative inotropic effects induced by
MICOTIL in dogs. Beta-adrenergic antagonists, such as propranolol, exacerbated the
negative inotropy of MICOTIL in dogs. Adrenaline potentiated lethality of MICOTIL in
pigs. This antibiotic persists in tissues for several days.

Section 5 - Fire Fighting Measures

Auto Ignition: 784掳F (418掳C)
Flash Point: Not applicable.
UEL: Not established.
LEL: Not flammable at temperatures up to 212掳F (100掳C). No ignition up to 20.0% volume
in air.

Extinguishing Media: Use water, carbon dioxide, dry chemical, foam, or Halon.

Unusual Fire and Explosion Hazards: None known.

Hazardous Combustion Products: May emit toxic fumes when exposed to heat or fire.

Section 6 - Accidental Release Measures

Spills: Prevent further migration into the environment. Use absorbent/adsorbent material to
solidify liquids. Sweep up or vacuum. Wear protective equipment, including eye protection,
to avoid exposure (see Section 8 for specific handling precautions). Large spills due to traffic
accidents, etc., should be reported immediately to Elanco Animal Health for assistance.
Prevent spilled material from flowing onto adjacent land or into streams, ponds, or lakes.
Page 4 of 8

Section 7 - Handling and Storage

Storage: Store below 30掳C (Room Temperature). Protect from direct sunlight. Use all
product within 90 days of opening and discard any unused portion.

Human Warnings
Injection of MICOTIL Injection of Micotil 300 in humans has been associated with fatalities.
Keep out of reach of children. Do not use in automatically powered syringes. Exercise
extreme caution to avoid accidental self-injection. In case of human injection, consult a
doctor immediately and apply ice or cold pack to injection site while avoiding direct contact
with the skin. Contact Poisons Information Centre on 13 1126. Avoid contact with eyes. Do
not massage injection site.

Section 8 - Exposure Controls / Personal Protection

See Section 2 for Exposure Guideline information.

Respiratory Protection: Use an approved respirator.

Eye Protection: Chemical goggles and/or face shield.

Ventilation: Laboratory fume hood or local exhaust ventilation.

Other Protective Equipment: In a manufacturing setting, wear chemical-resistant gloves and
body covering to minimize skin contact. If handled in a ventilated enclosure, as in a
laboratory setting, respirator and goggles or face shield may not be required. Safety glasses
are always required.

Other Handling Precautions: Under normal use and handling conditions, wear goggles to
protect eyes and wear impermeable gloves and protective equipment to avoid direct contact
with skin. Wash thoroughly with soap and water after handling.

Section 9 - Physical and Chemical Properties

Appearance: Clear yellow to amber-coloured solution
Physical State: Liquid
Odor: Faint characteristic sweet odour
Boiling Point: No applicable information found.
Melting Point: Not applicable.
Specific Gravity: No applicable information found.
pH: 5.5 to 6.5 (aqueous 50/50).
Evaporation Rate: No applicable information found.
Water Solubility: Soluble.
Vapour Density: No applicable information found.
Vapour Pressure: No applicable information found.
Page 5 of 8

Section 10 - Stability and Reactivity

Stability: Stable at normal temperatures and pressures.

Incompatibility: May react with strong oxidizing agents (e.g., peroxides, permanganates,
nitric acid, etc.).

Hazardous Decomposition: May emit toxic fumes when heated to decomposition.

Hazardous Polymerization: Not known to occur.

Section 11 - Toxicological Information
Animal Toxicity Data Single Exposure
Data for tilmicosin phosphate and Micotil 300 Injection are reported as indicated.

Oral: Tilmicosin phosphate - Rat (fasted), median lethal dose 855 mg/kg, reduced activity,
incoordination, drooping eyelids, soft stools, whole body thin, distended abdomen.

Skin: Micotil 300 Injection - Rabbit, 0.5 mL/kg, no deaths or toxicity.

Inhalation: Micotil 300 Injection - Rat, 2750 mg/m3 for 4 hours, no deaths, reduced activity,
labored breathing, blood in urine.

Subcutaneous: Micotil 300 Injection - Rat, median lethal dose 318 mg/kg, reduced activity,
leg weakness, hunched posture.
Tilmicosin phosphate - Rat, median lethal dose 185 mg/kg, coma, lethargy, incoordination,
reduced activity.

Intramuscular: Micotil 300 Injection - Monkey, a single dose of 10 mg/kg caused no signs of
toxicity. A single dose of 20 mg/kg caused vomiting, and 30 mg/kg caused the death of the
only monkey tested.
Swine, intramuscular injection of 10 mg/kg caused increased respiration, emesis, and a
convulsion, 20 mg/kg resulted in mortality in 3 of 4 pigs, and 30 mg/kg caused the death of
all 4 pigs tested.

Skin Contact: Micotil 300 Injection - Rabbit, slight irritant.

Eye Contact: Micotil 300 Injection - Rabbit, slight irritant.

Animal Toxicity Data Repeat Exposure
No data available for mixture or formulation. Data for ingredient(s) or related material(s) are

Target Organ Effects: Tilmicosin phosphate - Heart effects (increased heart weight and size,
heart muscle degeneration characterized by small areas of cell death, severe and persistent
increase in heart rate with changes in electrocardiogram ST, Q, and T wave forms occurred
generally at higher oral or injection doses where some mortality occurred), liver effects
(increased liver weight and enzyme activity).
Page 6 of 8

Other Effects: Tilmicosin phosphate - Increased adrenal and kidney weights, increased cell
size in adrenal cortex, mucosal edema of the gallbladder, and subretinal fluid accumulation.
Decreased food consumption and body weight gains, slightly decreased urine pH, occult
blood in urine, increased serum alanine transaminase.

Reproduction: Tilmicosin phosphate - No effects identified in animal studies, except slight
increase in offspring mortality at maternally toxic doses.

Sensitization: Tilmicosin phosphate - Not a contact sensitizer in guinea pigs.

Mutagenicity: Tilmicosin - Not mutagenic in bacterial or mammalian cells.

Section 12 - Ecological Information

No environmental data for the mixture or formulation. The environmental data for
ingredient(s) or related material(s) are presented.

Ecotoxicity Data: Tilmicosin
Rainbow trout 96-hr median lethal concentration: 851 mg/L
Bluegill 96-hr median lethal concentration: 716 mg/L
Daphnia magna 48-hr median effective concentration: 57.3 mg/L
Bobwhite 5-day dietary median lethal concentration: > 4820 ppm
Mallard 5-day dietary median lethal concentration: > 4710 ppm
Earthworm 28-day median lethal concentration: > 918 mg/kg
Green algae (S. capricornutum) median effective concentration: 0.354 mg/L (average specific
growth rate)
Plant growth in soil for most species unaffected at 100 mg/L
fungus (Chaetomium globosum): MIC > 1000 mg/L
mold (Aspergillus flavus): MIC > 1000 mg/L
soil bacteria (Comamonas acidovorans): MIC = 250 mg/L
N-fixing bact. (Azotobacter chroococcum): MIC = 5 mg/L
blue-green algae (Nostoc sp.): MIC = 0.5 mg/L

Environmental Fate: Tilmicosin
Log Kow: <1, <1, 2.6 (pH 5, 7, 9)
Adsorption coefficients (K): 129, 181, 318 (sandy loam, loam, clay loam)
Water solubility (g/L): 566, 7.7 (pH 7, 9)
Photolysis half-life (hours): 0.84, 0.82, 0.82 (pH 5, 7, 9)
Photolysis rate constant (1/hours): 0.83, 0.84, 0.84 (pH 5, 7, 9)
Hydrolysis half-life (days): >= 365, >= 365, 156 (pH 5, 7, 9)
Hydrolysis rate constant (1/hours): 0.0001853 (pH 9)
Aerobic biodegradation: none measured after 64 days (sandy loam, loam, clay loam)
Anaerobic biodegradation: none measured after 73 days
Decline in loam soil: 45.9% after 52 weeks
Decline in clay loam soil: none after 52 weeks
Page 7 of 8

Environmental Summary: Tilmicosin
Practically nontoxic to fish, birds, earthworms, fungus, molds, soil bacteria, and most plants.
Slightly toxic to aquatic invertebrates. Moderately toxic to nitrogen-fixing bacteria. Highly
toxic to green algae and blue-green algae. No volatility expected. Low potential to
bioconcentrate in aquatic organisms. Low mobility in soil. Persistent in the soil
environment. Persistence in the aquatic environment not expected due to rapid photolysis.

Lilly Aquatic Exposure Guideline (LAEG): Tilmicosin
LAEG for Drinking Water: 280 micrograms/L
LAEG for Chronic Exposure of Aquatic Organisms: 54 micrograms/L
LAEG for Acute Exposure of Aquatic Organisms: 354 micrograms/L

Section 13 - Disposal Considerations

Disposal: Dispose of empty container by wrapping with paper and putting in garbage.
Discarded needles should immediately be placed in a designated and appropriately labelled
"sharps" container.

Section 14 - Transport Information

No special transport requirements necessary.

Section 15 - Other Information

Sections revised: Removed automatic print date from header.
Section 4 and 7 re Human Warnings.
Section 15:Added Chemwatch details to Contacts

As of the date of issuance, we are providing available information relevant to the handling of
this material in the workplace. All information contained herein is offered with the good
faith belief that it is accurate. THIS MATERIAL SAFETY DATA SHEET SHALL NOT BE
of an adverse incident associated with this material, this safety data sheet is not intended to be
a substitute for consultation with appropriately trained personnel. Nor is this safety data
sheet intended to be a substitute for product literature which may accompany the finished

24 hour emergency contact number, CHEMWATCH 1800 039 008

Elanco Animal Health, West Ryde, N.S.W. (refer contact numbers on page 1 of this
Page 8 of 8


ACGIH = American Conference of Governmental Industrial Hygienists
AIHA = American Industrial Hygiene Association
BEI = Biological Exposure Index
CAS Number = Chemical Abstract Service Registry Number
CERCLA = Comprehensive Environmental Response Compensation and Liability Act (of
CHEMTREC = Chemical Transportation Emergency Center
DOT = Department of Transportation
EC = European Community
EINECS = European Inventory of Existing Chemical Substances
ELINCS = European List of New Chemical Substances
EPA = Environmental Protection Agency
HEPA = High Efficiency Particulate Air (Filter)
IARC = International Agency for Research on Cancer
ICAO/IATA = International Civil Aviation Organization/International Air Transport
IEG = Lilly Interim Exposure Guideline
IMO = International Maritime Organization
LEG = Lilly Exposure Guideline
LEL = Lower Explosive Limit
MSDS = Material Safety Data Sheet
NA = Not Applicable, except in Section 14 where NA = North America
NADA = New Animal Drug Application
NAIF = No Applicable Information Found
NCI = National Cancer Institute
NIOSH = National Institute for Occupational Safety and Health
NOS = Not Otherwise Specified
NTP = National Toxicology Program
OSHA = Occupational Safety and Health Administration
PEL = Permissible Exposure Limit (OSHA)
RCRA = Resource Conservation and Recovery Act
RQ = Reportable Quantity
RTECS = Registry of Toxic Effects of Chemical Substances
SARA = Superfund Amendments and Reauthorization Act
STEG = Lilly Short Term Exposure Guideline
STEL = Short Term Exposure Limit
TLV = Threshold Limit Value (ACGIH)
TPQ = Threshold Planning Quantity
TSCA = Toxic Substances Control Act
TWA = Time Weighted Average/8 Hours Unless Otherwise Noted
UEL = Upper Explosive Limit
UN = United Nations
WEEL = Workplace Environmental Exposure Level (AIHA)

67-63-0.asp 67-63-0 110-54-3
67-63-0.asp 67-63-0
7775-09-9.asp 7775-09-9 7647-14-5 10588-01-9
7704-34-9.asp 7704-34-9 7783-06-4
7446-09-5.asp 7446-09-5
68391-01-5.asp 68391-01-5
chemvet_com_au_MSDSVetmecACI.asp N/A
7440-43-9.asp 7440-43-9 1306-19-0 21041-95-2 7440-48-4 1307-96-6 21041-93-0 1310-65-2 7440-02-0 1313-99-1 12054-48-7 1310-58-3
74-78-6.asp 74-78-6 75-28-5
chppmapgea_army_mil_hazmat_field_guide_24_sep_01.asp N/A
10043-35-3.asp 10043-35-3 64742-48-9 811-97-2 75-37-6 7631-86-9
117704-25-3.asp 117704-25-3
137330-13-3.asp 137330-13-3
108-65-6.asp 108-65-6 1119-40-0 627-93-0 106-65-0 34590-94-8
50-30-4.asp 50-30-4
28-22-8.asp 28-22-8
26628-22-8.asp 26628-22-8 77-86-1 9002-93-1
cisbiointernational_fr_MESOMARK_MSDS.asp N/A
117-81-7.asp 117-81-7
110-19-0.asp 110-19-0 142-82-5 7732-18-5 64-17-5 67-64-1 64-19-7 67-56-1 33069-62-4
12-05-0.asp 12-05-0 7664-38-2 7697-37-2 64-19-7
108-90-7.asp 108-90-7
7440-47-3.asp 7440-47-3
77-92-9.asp 77-92-9
12125-01-8.asp 12125-01-8 7664-39-3 7732-18-5
7664-39-3.asp 7664-39-3 7732-18-5
7647-01-0.asp 7647-01-0 7758-94-3
7664-38-2.asp 7664-38-2 7732-18-5
109-99-9.asp 109-99-9
7719-09-7.asp 7719-09-7
7440-33-7.asp 7440-33-7
7732-18-5.asp 7732-18-5 050-81-7 97-67-6 77-92-9 56-81-5 72968-50-4
citrusdepot_net_MSDS_for_all_Products.asp N/A
citytech_com_MSDS_5__Electrolyte_RM121.asp N/A
143-33-9.asp 143-33-9
109-65-9.asp 109-65-9
112-30-1.asp 112-30-1
1319-77-3.asp 1319-77-3
5989-27-5.asp 5989-27-5 64742-94-5 75-28-5 74-98-6 106-97-8
cjmillerllc_com_000469.asp N/A
clawel_com_SprayGrade_AmmoniumSulfate_msds.asp N/A
25038-59-9.asp 25038-59-9
cleanersolutions_org_Vertrel_CCA_TDS.asp N/A
9016-45-9.asp 9016-45-9 15630-89-4 6834-92-0 9014-01-1 9000-90-2 9001-62-1
8008-20-6.asp 8008-20-6 64742-88-7
127-18-4.asp 127-18-4
5989-27-5.asp 5989-27-5
68551-19-9.asp 68551-19-9 111-76-2
6834-92-0.asp 6834-92-0
cleantec_com_au_TailPaint_aerosol_msds.asp N/A


Chemical Information Net chemcas.orgCopyright Reserved

Trading Lead

Leputech HPLC Laboratory